"Paxlovid is not a drug that gets you better faster. It's not a drug that decreases long COVID," Adalja said. "It's a drug that prevents you from being hospitalized or dying." ...

Paxlovid, an antiviral treatment for Covid-19, was hailed as a game-changer in the pandemic thanks to its strong performance in lowering the risk of severe disease. Early supply challenges have ...

Item 1 of 2 Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken in Medford, Massachusetts, U.S., May 12, 2022.

Paxlovid, an antiviral therapy that is prescribed to COVID-19 patients to prevent severe illness, soon will cost more than double the $529 that the federal government had paid for the treatment.

Everything we know about Paxlovid, the COVID-19 pill that’s saving lives Experts explain how the drug works, where it came from, and what kinds of side effects to expect ...

Paxlovid, available since December 2021, reduced the COVID-19 death rate in high-risk patients by 73%, according to a study National Institutes of Health researchers released last year. Yet uptake ...

State-licensed pharmacists can now prescribe Paxlovid, alongside doctors, as a COVID-19 treatment for people who are eligible to receive it, the FDA says.

Pfizer, Paxlovid’s manufacturer, found in its own study of the drug that rebound occurs in about 1.7% of Paxlovid patients, which is slightly lower than what they found in the untreated, ...

A U.S. Food and Drug Administration analysis did not find a clear association between the COVID-19 antiviral drug Paxlovid and illness rebound, the FDA said in a new report.. Rebound rates are ...

Reports of Post-Paxlovid Covid-19 Rebound Cases But No Formal Studies Yet. For example, there’s that pre-print case report uploaded to Research Square on April 26, 2022, of a 71-year-old man who ...

Though Paxlovid has been proven effective in reducing hospitalizations and deaths in high-risk Covid patients, some people have become wary of the medication because a small percentage of patients ...